Emotional Support

You may feel a mixture of emotions following a blood cancer diagnosis. We’re here to help you cope with the emotional impact of being diagnosed and living with a blood cancer.

There is no right or wrong way to feel or react to a blood cancer diagnosis because it affects everyone differently. If you’re struggling with your emotions following a diagnosis, there is lots of help available and information on ways to manage your feelings.

Your feelings and emotions

A diagnosis of a blood cancer can affect you emotionally as well as physically. We can help you to understand what you’re going through.

Coping with a blood cancer

Even though you may feel low and unable to feel like anything will help, there are a number of things you can do to help yourself feel a bit better.

When someone close to you has a blood cancer

Hearing the news that someone you love has a blood cancer can be one of the most overwhelming and devastating times of your life. Whatever your relationship with that person, it’s natural to feel a range of emotions.

Coping with bereavement

For most of us, losing a loved one can be devastating and lonely. Grief is what you will normally experience when somebody you are close to dies and it affects people in different ways.

Keeping it safe and legal

Fundraising is supposed to be fun (the clue is in the name), but you still have to make sure that your event or challenge follows the rules. If you don’t, your event might not end up being so fun after all.

Read More

Take a Moment to Catch Up

View our latest news and blog articles

September 18th

CVs – a how-to guide

In our second blog on getting back to work, we look at CVs, their uses, and how to write one....

September 16th

Blood Cancer Awareness Month so far

We’re halfway through Blood Cancer Awareness Month and our Spot Leukaemia campaign. Here, we round up the campaign so far....

September 7th

The Scottish Medicine Consortium (SMC) approves gilteritinib for relapsed/refractory AML patients in Scotland

The Scottish Medicine Consortium (SMC) has recommended the use of gilteritinib for patients who have relapsed or refractory acute myeloid leukaemia (AML) with a FLT3 mutation. Find out what this means for patients in Scotland here....